These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27462596)

  • 1. Analysis of falsely elevated risk of ovarian malignancy algorithm in women with ovarian endometrioma.
    Shin JJ; Lee YJ; Kim R; Lee da Y; Won KH; Jee BC
    Obstet Gynecol Sci; 2016 Jul; 59(4):295-302. PubMed ID: 27462596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of HE4, CA-125, Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal Mass.
    Al Musalhi K; Al Kindi M; Al Aisary F; Ramadhan F; Al Rawahi T; Al Hatali K; Mula-Abed WA
    Oman Med J; 2016 Sep; 31(5):336-44. PubMed ID: 27602187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer.
    Wei SU; Li H; Zhang B
    Biomed Rep; 2016 Jul; 5(1):41-44. PubMed ID: 27347403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified HE4, CA125, and ROMA cut-off values and predicted probability of ovarian tumor in Chinese patients.
    Zhao X; Zhao M; Gao B; Zhang A; Xu D
    Gland Surg; 2021 Nov; 10(11):3097-3105. PubMed ID: 34926225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of applicability of HE4 and ROMA in the preoperative diagnosis of adnexal masses].
    Janas L; Głowacka E; Wilczyński JR; Malinowski A; Nowak M
    Ginekol Pol; 2015 Mar; 86(3):193-7. PubMed ID: 25920309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay.
    Yang J; Sa M; Huang M; Yang J; Xiang Z; Liu B; Tang A
    Clin Biochem; 2013 Nov; 46(16-17):1705-8. PubMed ID: 24012857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new strategy for calculating the risk of ovarian malignancy algorithm (ROMA).
    Jeong TD; Cho EJ; Ko DH; Lee W; Chun S; Kwon HJ; Hong KS; Kim YM; Min WK
    Clin Chem Lab Med; 2017 Jul; 55(8):1209-1214. PubMed ID: 28107166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation in the predictive value of serum human epididymal protein 4 (HE4), cancer antigen 125 (CA 125) and a combination of both in detecting ovarian malignancy.
    Teh BH; Yong SL; Sim WW; Lau KB; Suharjono HN
    Horm Mol Biol Clin Investig; 2018 Jul; 35(1):. PubMed ID: 30063463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative value of CA-125, HE4, Risk of Malignancy Index II (RMI-II) and Risk of Malignancy Algorithm (ROMA) in the differential diagnosis of pelvic masses: conclusions from a referral Centre in Portugal.
    Melo Â; Veríssimo R; Farinha M; Martins NN; Martins FN
    J Obstet Gynaecol; 2018 Nov; 38(8):1140-1145. PubMed ID: 29884096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proofs for implementation of higher HE4 and ROMA index cut-off values in ovarian cancer preoperative stratification.
    Špacir Prskalo Z; Bulić P; Langer S; Gaće M; Puljiz M; Danolić D; Alvir I; Mamić I; Šušnjar L; Mayer L
    J Obstet Gynaecol; 2019 Feb; 39(2):195-201. PubMed ID: 30207507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adnexal mass with extremely high levels of CA-125 and CA19-9 but normal Human Epididymis Protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA): Endometriosis or ovarian malignancy? A case report.
    Khodaverdi S; Amini-Moghaddam S; Almassi Nokiani F; Hashemi N; Mohammad Beigi R
    Int J Reprod Biomed; 2018 Jun; 16(6):413-416. PubMed ID: 30123870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages.
    Kotowicz B; Fuksiewicz M; Sobiczewski P; Spiewankiewicz B; Jonska-Gmyrek J; Skrzypczak M; Kowalska M
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():141-6. PubMed ID: 26398337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma].
    Wang MJ; Qi J; Wang H; Li XX; Wei BJ; Fu C; Gao J; Han BB
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HE4, CA125, the Risk of Malignancy Algorithm and the Risk of Malignancy Index and complex pelvic masses - a prospective comparison in the pre-operative evaluation of pelvic masses in an Australian population.
    Richards A; Herbst U; Manalang J; Pather S; Saidi S; Tejada-Berges T; Tan K; Williams P; Carter J
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):493-7. PubMed ID: 26172511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
    Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
    Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients.
    Li QL; Wang CJ; Qi P; Zhang YX
    Clin Transl Oncol; 2017 Oct; 19(10):1260-1267. PubMed ID: 28444641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
    Montagnana M; Danese E; Ruzzenente O; Bresciani V; Nuzzo T; Gelati M; Salvagno GL; Franchi M; Lippi G; Guidi GC
    Clin Chem Lab Med; 2011 Mar; 49(3):521-5. PubMed ID: 21288178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125.
    Chudecka-Głaz A; Cymbaluk-Płoska A; Luterek-Puszyńska K; Menkiszak J
    Oncol Lett; 2016 Nov; 12(5):3101-3114. PubMed ID: 27899969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Falsely elevated human epididymis protein 4 results and Risk of Ovarian Malignancy Algorithm in polymorbid women after solid organ transplantation: A pilot and case-control study.
    Franeková J; Cindr J; Lavríková P; Komrsková J; Sečník P; Lánská V; Jabor A
    J Clin Lab Anal; 2018 Jul; 32(6):e22432. PubMed ID: 29575276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.